SCHEMBL31347335

SCHEMBL31347335

C[C@@H](O)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)O

nearest known ligand 0.56

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ OPRL1 P41146 8/20 0.56
▸ OPRM1 P35372 2/20 0.50
▸ OPRD1 P41143 2/20 0.50
▸ OPRK1 P41145 1/20 0.50
▸ TFPI P10646 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30721650 0.97 OPRM1 (0.55) OPRL1OPRM1OPRD1OPRK1TFPI
SCHEMBL29436306 0.93 OPRM1 (0.54) OPRL1OPRM1OPRD1OPRK1
SCHEMBL30974061 0.91 OPRL1 (0.59) OPRL1OPRM1OPRD1OPRK1
SCHEMBL29674783 0.90 OPRM1 (0.53) OPRL1OPRM1OPRD1OPRK1
SCHEMBL30467092 0.90 TFPI (0.62) OPRM1OPRD1OPRK1TFPI
SCHEMBL29436286 0.89 OPRM1 (0.55) OPRL1OPRM1OPRD1OPRK1
SCHEMBL29375389 0.88 BACE1 (0.56) OPRM1OPRD1
SCHEMBL29375740 0.88 BACE1 (0.56) OPRM1OPRD1
SCHEMBL30974017 0.88 OPRL1 (0.62) OPRL1OPRM1OPRD1OPRK1
SCHEMBL30974537 0.87 OPRL1 (0.58) OPRL1OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724472-A2 GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS Sun Pharmaceutical Industries Limited (IN) 2026-04-15 — — EP claimed
WO-2024252367-A2 NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2024-12-12 — — WO claimed
EP-4724472-A2 GLP-1/GIP DUAL, GLP-1/GCG DUAL AND GLP-1/GIP/GCG TRIPLE RECEPTOR AGONISTS Sun Pharmaceutical Industries Limited (IN) 2026-04-15 — — EP disclosed
WO-2024252367-A2 NOVEL GLP-1/GIP DUAL AND GLP-1/GCG DUAL RECEPTOR AGONISTS SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) 2024-12-12 — — WO disclosed
Send feedback